Literature DB >> 11471873

Reference intervals for thyroid hormones in pregnant Chinese women.

N S Panesar1, C Y Li, M S Rogers.   

Abstract

OBJECTIVE: To establish gestation-related reference intervals for thyroid hormones in a Chinese population.
MATERIALS AND METHODS: A prospective study with 343 healthy pregnant women (5-41 weeks) and 63 non-pregnant controls. Thyroid stimulating hormone (TSH), free thyroxine (T4) and tri-iodothyronine (T3) (and human chorionic gonadotrophin) were measured by immunoassays. The median, 2.5th and 97.5th percentiles at 4-week intervals were calculated. Data were also analysed for significant trends using ANOVA.
RESULTS: Free T3 decreased during pregnancy, whereas free T4 initially increased, peaking between 9-13 weeks and then decreased, the decline becoming significant by week 21. TSH mirrored changes in free T4.
CONCLUSION: The gestation-related reference intervals for thyroid hormones should alleviate the misinterpretation of thyroid function in pregnancy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11471873     DOI: 10.1258/0004563011900830

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  40 in total

1.  Thyroid nodule and differentiated thyroid cancer management in pregnancy. An Italian Association of Clinical Endocrinologists (AME) and Italian Thyroid Association (AIT) Joint Statement for Clinical Practice.

Authors:  E Papini; R Negro; A Pinchera; R Guglielmi; A Baroli; P Beck-Peccoz; P Garofalo; M P Pisoni; M Zini; R Elisei; L Chiovato
Journal:  J Endocrinol Invest       Date:  2010-07-13       Impact factor: 4.256

2.  Gestation-specific thyroxine and thyroid stimulating hormone levels in the United States and worldwide.

Authors:  Offie P Soldin; Danielle Soldin; Marisol Sastoque
Journal:  Ther Drug Monit       Date:  2007-10       Impact factor: 3.681

3.  Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy.

Authors:  Natasa Kahric-Janicic; Steven J Soldin; Offie P Soldin; Threvia West; Jianghong Gu; Jacqueline Jonklaas
Journal:  Thyroid       Date:  2007-04       Impact factor: 6.568

4.  Iodine in pregnancy: is salt iodization enough?

Authors:  Elizabeth N Pearce
Journal:  J Clin Endocrinol Metab       Date:  2008-07       Impact factor: 5.958

Review 5.  [Thyroid illness during pregnancy].

Authors:  D Führer
Journal:  Internist (Berl)       Date:  2011-10       Impact factor: 0.743

6.  Hyperthyroidism and pregnancy. An Italian Thyroid Association (AIT) and Italian Association of Clinical Endocrinologists (AME) joint statement for clinical practice.

Authors:  R Negro; P Beck-Peccoz; L Chiovato; P Garofalo; R Guglielmi; E Papini; M Tonacchera; F Vermiglio; P Vitti; M Zini; A Pinchera
Journal:  J Endocrinol Invest       Date:  2011-03-22       Impact factor: 4.256

7.  Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum.

Authors:  Alex Stagnaro-Green; Marcos Abalovich; Erik Alexander; Fereidoun Azizi; Jorge Mestman; Roberto Negro; Angelita Nixon; Elizabeth N Pearce; Offie P Soldin; Scott Sullivan; Wilmar Wiersinga
Journal:  Thyroid       Date:  2011-07-25       Impact factor: 6.568

8.  High prevalence of thyroid dysfunction in pregnant women.

Authors:  M Altomare; S La Vignera; P Asero; D Recupero; R A Condorelli; P Scollo; A Gulisano; E Magro; D Tumino; S Tumino; E Vicari; V Leanza; R D'Agata; A E Calogero
Journal:  J Endocrinol Invest       Date:  2012-10-22       Impact factor: 4.256

9.  Effect of thyroid peroxidase antibodies on thyroid-stimulating hormone reference limits in a primarily Latina population.

Authors:  Richard H Lee; Carole A Spencer; Martin N Montoro; Paola Aghajanian; T Murphy Goodwin; Erin A Miller; Ivana Petrovic; Lewis E Braverman; Jorge H Mestman
Journal:  Obstet Med       Date:  2009-11-30

Review 10.  Autoimmune thyroid disease in pregnancy: a review.

Authors:  Juan C Galofre; Terry F Davies
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.